BACKGROUND AND AIMS: Vitamin D exists as an inactive 25-hydroxyvitamin D (25(OH)D) in the bloodstream, which is converted to active 1,25-dihydroxyvitaminD (1,25(OH)2D) in target tissues. Cohort studies reporting cardiovascular disease among individuals with low vitamin D are inconsistent and solely measure 25(OH)D. Psoriasis, a chronic inflammatory disease, is a vitamin D deficient state and is associated with increased cardiovascular disease risk. While serum 25(OH)D is routinely measured, we hypothesized that measurement of 1,25(OH)2D in psoriasis may perform better than 25(OH)D in capturing cardiovascular risk. METHODS: Consecutive psoriasis patients (N = 122) at baseline underwent FDG PET/CT and CCTA scans to measure visceral adipose volume, aortic vascular uptake of FDG, and coronary plaque burden respectively. Blood levels of both 1,25(OH)2D and 25(OH)D were measured by chemiluminescence (LIAISON XL DIaSorin, Stillwater, MN). RESULTS: The psoriasis cohort was middle-aged (mean ± SD: 49.6 ± 13.0), predominantly male (n = 71, 58%), in majority Caucasians (n = 98, 80%), and had moderate-to-severe skin disease [psoriasis area severity index score, PASI score, med. (IQR): 5.5 (3.2-10.7)], with almost one-fourth of the cohort on biologic psoriasis therapy for skin disease management (n = 32, 27%) at baseline. Interestingly, serum levels of 1,25(OH)2D but not 25(OH)D were found to be inversely associated with visceral adipose, a marker of cardiometabolic risk in fully adjusted models (β = - 0.43, p = 0.026 and β = -0.26 p = 0.13). Similarly, we found an inverse relationship between 1,25(OH)2D, but not 25(OH)D, and aortic vascular uptake of FDG independent of traditional risk factors (β = -0.19, p = 0.01). Finally, we found that serum 1,25(OH)2D, but not 25(OH)D, was inversely associated with non-calcified coronary plaque burden, as measured by CCTA independent of traditional risk factors (β = -0.18, p = 0.03). CONCLUSIONS: In conclusion, we demonstrate that low 1,25(OH)2D levels were associated with visceral adipose volume, vascular uptake of FDG and coronary plaque burden independent of traditional risk factors, suggesting that 1,25(OH)2D may better capture the cardiometabolic risk associated with vitamin D deficient states. Published by Elsevier B.V.
BACKGROUND AND AIMS: Vitamin D exists as an inactive 25-hydroxyvitamin D (25(OH)D) in the bloodstream, which is converted to active 1,25-dihydroxyvitaminD (1,25(OH)2D) in target tissues. Cohort studies reporting cardiovascular disease among individuals with low vitamin D are inconsistent and solely measure 25(OH)D. Psoriasis, a chronic inflammatory disease, is a vitamin D deficient state and is associated with increased cardiovascular disease risk. While serum 25(OH)D is routinely measured, we hypothesized that measurement of 1,25(OH)2D in psoriasis may perform better than 25(OH)D in capturing cardiovascular risk. METHODS: Consecutive psoriasispatients (N = 122) at baseline underwent FDG PET/CT and CCTA scans to measure visceral adipose volume, aortic vascular uptake of FDG, and coronary plaque burden respectively. Blood levels of both 1,25(OH)2D and 25(OH)D were measured by chemiluminescence (LIAISON XL DIaSorin, Stillwater, MN). RESULTS: The psoriasis cohort was middle-aged (mean ± SD: 49.6 ± 13.0), predominantly male (n = 71, 58%), in majority Caucasians (n = 98, 80%), and had moderate-to-severe skin disease [psoriasis area severity index score, PASI score, med. (IQR): 5.5 (3.2-10.7)], with almost one-fourth of the cohort on biologic psoriasis therapy for skin disease management (n = 32, 27%) at baseline. Interestingly, serum levels of 1,25(OH)2D but not 25(OH)D were found to be inversely associated with visceral adipose, a marker of cardiometabolic risk in fully adjusted models (β = - 0.43, p = 0.026 and β = -0.26 p = 0.13). Similarly, we found an inverse relationship between 1,25(OH)2D, but not 25(OH)D, and aortic vascular uptake of FDG independent of traditional risk factors (β = -0.19, p = 0.01). Finally, we found that serum 1,25(OH)2D, but not 25(OH)D, was inversely associated with non-calcified coronary plaque burden, as measured by CCTA independent of traditional risk factors (β = -0.18, p = 0.03). CONCLUSIONS: In conclusion, we demonstrate that low 1,25(OH)2D levels were associated with visceral adipose volume, vascular uptake of FDG and coronary plaque burden independent of traditional risk factors, suggesting that 1,25(OH)2D may better capture the cardiometabolic risk associated with vitamin D deficient states. Published by Elsevier B.V.
Entities:
Keywords:
Coronary artery disease; Imaging; Inflammation; Psoriasis; Vitamin D
Authors: Pawel Pludowski; Michael F Holick; William B Grant; Jerzy Konstantynowicz; Mario R Mascarenhas; Afrozul Haq; Vladyslav Povoroznyuk; Nataliya Balatska; Ana Paula Barbosa; Tatiana Karonova; Ema Rudenka; Waldemar Misiorowski; Irina Zakharova; Alena Rudenka; Jacek Łukaszkiewicz; Ewa Marcinowska-Suchowierska; Natalia Łaszcz; Pawel Abramowicz; Harjit P Bhattoa; Sunil J Wimalawansa Journal: J Steroid Biochem Mol Biol Date: 2017-02-12 Impact factor: 4.292
Authors: Paolo Raggi; Jacques Genest; Jon T Giles; Katey J Rayner; Girish Dwivedi; Robert S Beanlands; Milan Gupta Journal: Atherosclerosis Date: 2018-07-25 Impact factor: 5.162
Authors: Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel Journal: JAMA Date: 2006-10-11 Impact factor: 56.272
Authors: Andre Valcour; Claudia Zierold; Angela L Podgorski; Gregory T Olson; John V Wall; Hector F DeLuca; Fabrizio Bonelli Journal: J Steroid Biochem Mol Biol Date: 2015-08-21 Impact factor: 4.292
Authors: Taufiq Salahuddin; Balaji Natarajan; Martin P Playford; Aditya A Joshi; Heather Teague; Youssef Masmoudi; Mariana Selwaness; Marcus Y Chen; David A Bluemke; Nehal N Mehta Journal: Eur Heart J Date: 2015-07-18 Impact factor: 29.983
Authors: José Tuñón; Carmen Cristóbal; Nieves Tarín; Álvaro Aceña; María Luisa González-Casaus; Ana Huelmos; Joaquín Alonso; Óscar Lorenzo; Emilio González-Parra; Ignacio Mahíllo-Fernández; Ana María Pello; Rocío Carda; Jerónimo Farré; Fernando Rodríguez-Artalejo; Lorenzo López-Bescós; Jesús Egido Journal: PLoS One Date: 2014-04-18 Impact factor: 3.240
Authors: Daniel Chauss; Tilo Freiwald; Reuben McGregor; Bingyu Yan; Luopin Wang; Estefania Nova-Lamperti; Dhaneshwar Kumar; Zonghao Zhang; Heather Teague; Erin E West; Kevin M Vannella; Marcos J Ramos-Benitez; Jack Bibby; Audrey Kelly; Amna Malik; Alexandra F Freeman; Daniella M Schwartz; Didier Portilla; Daniel S Chertow; Susan John; Paul Lavender; Claudia Kemper; Giovanna Lombardi; Nehal N Mehta; Nichola Cooper; Michail S Lionakis; Arian Laurence; Majid Kazemian; Behdad Afzali Journal: Nat Immunol Date: 2021-11-11 Impact factor: 31.250
Authors: Chandra L Kakarala; Mohammad Hassan; Rishab Belavadi; Sri Vallabh Reddy Gudigopuram; Ciri C Raguthu; Harini Gajjela; Iljena Kela; Ibrahim Sange Journal: Cureus Date: 2021-11-17